These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4202067)

  • 41. [Pathogenesis of diabetes mellitus].
    Pfeiffer EF
    Hippokrates; 1968 Apr; 39(7):250-7. PubMed ID: 5716305
    [No Abstract]   [Full Text] [Related]  

  • 42. ["Artificial pancreas" in the treatment of diabetes mellitus].
    Spesivtseva VT; Shumakov VI; Seĭd-Guseĭnov AA; Mamaeva GG; Samoĭlov VD
    Ter Arkh; 1980; 52(12):88-91. PubMed ID: 6787727
    [No Abstract]   [Full Text] [Related]  

  • 43. Studies with insulin -I-131 in insulin resistant diabetes.
    Ibrahim MS; Abdel-Wahab MF; el-Deeb MR
    J Egypt Med Assoc; 1966; 49(11):720-7. PubMed ID: 5965036
    [No Abstract]   [Full Text] [Related]  

  • 44. [Fatty diabetes, insulin resistance and anti-insulin antibodies].
    Jacotot B; Navarro N; Delplanque B; Le Parco JC; Beaumont JL
    Nouv Presse Med; 1973 Apr; 2(17):1121-4. PubMed ID: 4707009
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients.
    Emanuelli G; Gatti G; Calcamuggi G; Anfossi G; Cotto A; Marcarino C; Camussi G; Ottone G
    Panminerva Med; 1981; 23(2):81-8. PubMed ID: 7033894
    [No Abstract]   [Full Text] [Related]  

  • 46. Insulin antibody formation. I. The influence of age, sex, infections, insulin dosage and regulation of diabetes.
    Andersen OO
    Acta Endocrinol (Copenh); 1972 Sep; 71(1):126-40. PubMed ID: 4678008
    [No Abstract]   [Full Text] [Related]  

  • 47. [Insulin resistance and insulin antibodies].
    Bemm H
    Dtsch Z Verdau Stoffwechselkr; 1967 Nov; 27(3):61-8. PubMed ID: 5595731
    [No Abstract]   [Full Text] [Related]  

  • 48. [Changes of carbohydrate metabolism in normal pregnancy and its relationship with placental lactogen concentrations].
    Cao X; Qin W; He Z
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):80-2. PubMed ID: 10682424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The rationale for the use of drugs in the treatment of diabetes mellitus.
    Kryston LJ; Shaw RA
    Semin Drug Treat; 1974; 3(4):365-75. PubMed ID: 4207077
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment with chlorpropamide-phenformin combination in adult, obese, ketosis-resistant diabetics.
    Lev-Ran AS
    Isr J Med Sci; 1971 Jun; 7(6):727-32. PubMed ID: 4997820
    [No Abstract]   [Full Text] [Related]  

  • 51. Optimal insulin delivery in diabetic ketoacidosis (DKA) and hyperglycemic, hyperosmolar nonketotic coma (HHNC).
    Kitabchi AE; Matteri R; Murphy MB
    Diabetes Care; 1982; 5 Suppl 1():78-87. PubMed ID: 6821307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of an artificial beta-cell (Biostator) in clinical practice].
    Andreev D; Arnaudov I; Veleva N; Todorova S
    Vutr Boles; 1980; 19(6):60-6. PubMed ID: 6782760
    [No Abstract]   [Full Text] [Related]  

  • 53. Medical grand rounds from the West Virginia University Hospital. Insulin resistance.
    Jones DL
    W V Med J; 1979 Sep; 75(9):264-70. PubMed ID: 384675
    [No Abstract]   [Full Text] [Related]  

  • 54. Insulin degradation in serum of a patient with apparent insulin resistance.
    Misbin RI; Almira EC; Cleman MW
    J Clin Endocrinol Metab; 1981 Feb; 52(2):177-80. PubMed ID: 7007401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [What is the responsibility of the anti-insulin antibodies in resistant diabetes?].
    Rosselin G; Bricaire H; Dérot M; Hamburger J; Péquignot H
    Presse Med (1893); 1968 Feb; 76(10):463-6. PubMed ID: 4170692
    [No Abstract]   [Full Text] [Related]  

  • 56. Insulin-antagonistic effects of counterregulatory hormones: clinical and mechanistic aspects.
    Smith U; Lager I
    Diabetes Metab Rev; 1989 Sep; 5(6):511-25. PubMed ID: 2670491
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum insulin and anti-insulin activity in diabetic acidosis.
    WILLEBRANDS AF
    Clin Chim Acta; 1960 Jul; 5():508-19. PubMed ID: 13844797
    [No Abstract]   [Full Text] [Related]  

  • 58. Relation between antibody and insulin dose.
    Devlin JG; Brien T; Stephenson N
    Br Med J; 1967 Mar; 1(5539):542-4. PubMed ID: 6017157
    [No Abstract]   [Full Text] [Related]  

  • 59. INSULIN ANTAGONISTS AND INHIBITORS.
    VALLANCE-OWEN J
    Adv Metab Disord; 1964; 13():191-215. PubMed ID: 14171617
    [No Abstract]   [Full Text] [Related]  

  • 60. Insulin antibodies, insulin dose, and diabetic control.
    Walford S
    Lancet; 1983 Feb; 1(8321):410-1. PubMed ID: 6130394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.